In the complex, heavily regulated Mexican pharmaceuticals market, Solórzano Linaldi stands out as a specialist boutique advising on the full spectrum of matters and constituting a go-to destination for disputes. Court appeals at the highest level are one of the hallmarks of the team, which acts in amparo cases as well as disputes against the health authority COFEPRIS. Major client Investigación Farmacéutica is one beneficiary of the firm’s expertise in navigating the Mexican drug marketing authorisation landscape, and alongside its client base of domestic and multinational market-leaders, the team is also frequently sought out by international law firms needing specialist Mexican counsel for their clients. Head of the department and co-founding partner Guillermo Solórzano has comprehensive knowledge of regulatory and pharmaceutical matters, but also assists with patent and trade mark litigation, along with administrative litigation - particularly in relation to sanitary issues. Fellow name-partner Luis López Linaldi is one of the foremost administrative and amparo litigators in the life sciences space, and also has strong knowledge of the sector’s import/export procedures. Senior associate Eréndira Frias is well versed in advising pharmaceutical and biotech companies on pharmaceutical, sanitary, and administrative litigation issues; and more junior associate Alan Osorio Aragón has strong regulatory and IP knowledge to support clients with product launches in Mexico.
Key clients
- Novagenic Mexico
- Pharmascience
Work highlights
- Advised Investigación Farmacéutica on the design and implementation of a legal strategy to terminate distribution agreements for two drugs with a French multinational company.
- Advised Laboratorios Corne (LC) on the application of rules applied by the United Nations Office for Project Services (UNOPS), during a public procurement legal proceeding initiated by UNOPS against LC.